Comorbidities in psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue SUPPL. 2, 2006, Pages 52-55

  Christophers, E ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Comorbidities; Crohn's disease; Psoriasis; Psoriatic arthritis; Pustular disease; Systemic comorbidities

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; HLA B27 ANTIGEN;

ACRODERMATITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 16Q; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; CROHN DISEASE; GENE LOCUS; HUMAN; HYPERLIPIDEMIA; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY;

EID: 33750352855     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01773.x     Document Type: Conference Paper

References (27)

1. Alibert JL. Précis Théorique et Pratique sur les Maladies de la Peau, Vol. 1. Caille et Ravier, Paris, 1818.
2. Willan R. On Cutaneous Diseases. London, 1808.
3. Finzi AF, Gibelli E. Psoriatic arthritis. Int J Dermatol 1991; 30: 1-7.
4. Sege-Peterson K, Wichester R. Psoriatic arthritis. In: Freedberg I, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, 1999: 522-533.
5. Sheehan NJ. The ramifications of HLA-B27. j Roy Soc Med 2004; 97: 10-14.
6. Rahman P, Schentag CT, Gladman DD. Immunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasis. Arthritis Rheum 1999; 42: 822-823.
7. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
8. Ho P, Bruce IN, Symmons D et al. Evidence for common genetic control pathways of inflammation for Crohn's disease and psoriatic arthritis. Arthritis Rheum 2005; 52: 3596-3602.
9. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982; 106: 323-330.
10. Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003; 48: 805-821.
11. Lee FI, Bellarys SV, Francis C. Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1991; 85: 962-963.
12. Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-793.
13. Wright S, Baker H. Generalized pustular psoriasis. In: Roenigk HH, Maibach HI, eds. Psoriasis, 2nd edn. Marcel Dekker, New York, 1991: 23-44.
14. Von Zumbusch L. Psoriasis und pustulöses exanthem. Arch Derm Syph Berl 1910; 99: 335-346.
15. Wright S, Baker H. Localized pustular psoriasis. In: Roenigk HH, Maibach HI, eds. Psoriasis, 2nd edn. Marcel Dekker, New York, 1991: 45-56.
16. Zachariae H, Overgaard PH, Kissmeyer NF, Lamm L. HLA antigens in pustular psoriasis. Dermatologica 1977; 154: 73-77.
17. Asumalahti K, Ameen M, Suomela S et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003; 120: 627-632.
18. Christophers E, Mrowietz U. Psoriasis. In: Freedberg I, Eisen AZ, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, 1999: 495-521.
19. Sattar N, McInnes I. Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Current Opinion Rheumatol 2005; 17: 286-292.
20. Dessein PH, Stanwix AE, Joffe BI. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: Acute phase response related decreased insulin resistance and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 2002; 4: R5.
21. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99: 469-475.
22. Pearce DJ, Morrison AE, Higgins KB et al. The comorbid state of psoriasis patients in a University dermatology practice. J Dermatol Treatment 2005; 16: 319-323.
23. Lindegard B. Diseases associated with psoriasis in a general population of 159 2 00 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
24. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not outpatients. Eur J Epidemiol 2004; 19: 225-230.
25. Weichenthal M, Schmitt DM, Suchan M, Christophers E. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res (in press).
26. 5Jacobson LT, Turesson C, Gulfe A et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular event in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1213-1218.
27. Wallenberg-Jonsson S, Johansson H, Öhman ML, Rantapää-Dahlquist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset. J Rheumatol 1999; 26: 2562-2571.